1. Home
  2. KURA vs BKSY Comparison

KURA vs BKSY Comparison

Compare KURA & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

N/A

Current Price

$8.78

Market Cap

841.6M

Sector

Health Care

ML Signal

N/A

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

N/A

Current Price

$35.15

Market Cap

726.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KURA
BKSY
Founded
2014
2013
Country
United States
United States
Employees
N/A
340
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
841.6M
726.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
KURA
BKSY
Price
$8.78
$35.15
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$25.56
$28.50
AVG Volume (30 Days)
2.2M
2.5M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,482,000.00
N/A
Revenue This Year
$28.28
$27.03
Revenue Next Year
$106.37
$29.21
P/E Ratio
N/A
N/A
Revenue Growth
25.24
N/A
52 Week Low
$5.45
$10.80
52 Week High
$12.49
$52.88

Technical Indicators

Market Signals
Indicator
KURA
BKSY
Relative Strength Index (RSI) 43.04 42.55
Support Level $7.77 $30.16
Resistance Level $10.16 $42.75
Average True Range (ATR) 0.66 4.00
MACD -0.18 -1.84
Stochastic Oscillator 12.46 10.35

Price Performance

Historical Comparison
KURA
BKSY

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: